Grimes & Company Inc. Has $251,000 Stock Holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Grimes & Company Inc. increased its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 33.0% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 2,784 shares of the exchange traded fund’s stock after buying an additional 691 shares during the quarter. Grimes & Company Inc.’s holdings in SPDR S&P Biotech ETF were worth $251,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Avior Wealth Management LLC boosted its stake in SPDR S&P Biotech ETF by 393.6% during the 4th quarter. Avior Wealth Management LLC now owns 385 shares of the exchange traded fund’s stock valued at $35,000 after purchasing an additional 307 shares during the last quarter. Tidemark LLC boosted its position in shares of SPDR S&P Biotech ETF by 101.5% during the third quarter. Tidemark LLC now owns 395 shares of the exchange traded fund’s stock valued at $39,000 after buying an additional 199 shares during the last quarter. Quintet Private Bank Europe S.A. purchased a new position in shares of SPDR S&P Biotech ETF during the third quarter valued at approximately $40,000. ORG Wealth Partners LLC bought a new stake in SPDR S&P Biotech ETF during the third quarter worth $44,000. Finally, Howe & Rusling Inc. purchased a new stake in SPDR S&P Biotech ETF in the 3rd quarter valued at $49,000.

SPDR S&P Biotech ETF Trading Down 0.6 %

Shares of NYSEARCA:XBI opened at $92.46 on Monday. SPDR S&P Biotech ETF has a 1-year low of $81.14 and a 1-year high of $105.47. The stock has a market cap of $7.05 billion, a PE ratio of 11.47 and a beta of 1.11. The stock’s fifty day simple moving average is $93.34 and its two-hundred day simple moving average is $96.90.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.